Experiment 175138

Worktypes

PHARMACOLOGY OF COMPOUND - IN VIVO

Compounds isolated

STREPTOMYCES ANTIBIOTIC IC-101

Details

PropertyValue
Pharmacology
DELAYED TYPE CUTANEOUS HYPERSENSITIVITY INHIBITION
Administration routeIP
OrganismStreptomyces albulus (STREPTOMYCETACEAE)
CitationUENO,M: AMEMIYA,M: SOMENO,T: MASUDA,T: IINUMA,H: NAGANAWA,H: HAMADA,M: ISHIZUKA,M: TAKEUCHI,T:. (1993). IC101, EXTRACELLULAR MATRIX ANTAGONIST PRODUCED BY STREPTOMYCES SP. MJ202-72F3. PRODUCTION, ISOLATION, STRUCTURE DETERMINATION AND BIOLOGICAL ACTIVITY.. 46(11)
Amount utilized
Compound isolated
Dose amount25.0 MCG
Number9
Qualitative resultACTIVE
AnimalMOUSE
Per unitKG
Dose expressionDOSE